<DOC>
	<DOCNO>NCT02733640</DOCNO>
	<brief_summary>The investigator seek evaluate influence pantoprazole , indicate less effective proton pump inhibitor , antiplatelet effect clopidogrel , stratification population accord presence cytochrome ( CYP ) 2C19 polymorphism .</brief_summary>
	<brief_title>Does Pantoprazole Reduce Anti-platelet Effect Clopidogrel ?</brief_title>
	<detailed_description>Participants treat maintenance dose 75 mg clopidogrel 100 mg aspirin daily previous PCI coronary stenting include study . Participants randomly assign either pantoprazole 40 mg once-daily group ranitidine 150 mg twice-daily group use computer-generated randomize table . An independent investigator generate random allocation sequence . Blood sample collect 9:00 day prior treatment ( day 0 ) day 9 . Measuring impedance perform one independent investigator blind manner .</detailed_description>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<criteria>Patients treat maintenance dose 75 mg clopidogrel 100 mg aspirin daily previous PCI coronary stenting include study . All patient receive standardized therapy load dose 600 mg clopidogrel hydrogen sulfate 400 mg aspirin . All participant normal platelet count ( 150,000450,000/mL ) . Patients severe liver disorder , current gastrointestinal disorder , current infection , congestive heart failure , know bleeding disorder well patient bivalirudin glycoprotein IIb/III antagonist within last 7 day exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>